SCHOTT strengthens its position in the Asian pharmaceutical market

First fully automated production line for pharmaceutical packaging sets new standards in India

11-Feb-2013 - India

With the opening of a high-tech facility in India, SCHOTT continues to strengthen its strategic position in the Asian pharmaceutical market. As with the existing production plant in the city of Daman, SCHOTT KAISHA, a joint venture in which SCHOTT holds a 50% stake, will run the new production facility, located in Jambusar in the western state of Gujarat.

The new plant will allow SCHOTT to increase production by 50%, bringing total annual output to about two billion ampoules, vials, syringes, and cartridges. According to various studies, the Indian pharmaceutical industry is growing by 14 to 17 percent a year, primarily due to strong domestic demand from a rising Indian middle class seeking better medical care.

Other news from the department business & finance

More news from our other portals

All FT-IR spectrometer manufacturers at a glance